{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:56:28Z","timestamp":1792083388431,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jceh.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T13:30:20Z","timestamp":1406208620000},"page":"347-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Infections After Orthotopic Liver Transplantation"],"prefix":"10.1016","volume":"4","author":[{"given":"Mark","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Seetharam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.07.004_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1399-3062.2011.00640.x","article-title":"Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundacion Santa Fe de Bogota, Colombia","volume":"13","author":"Vera","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4254\/wjh.v3.i4.83","article-title":"Infections in liver transplant recipients","volume":"3","author":"Romero","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2014.07.004_bib3","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.idc.2010.01.005","article-title":"Infection in organ transplantation: risk factors and evolving patterns of infection","volume":"24","author":"Fishman","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jceh.2014.07.004_bib5","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/lt.20624","article-title":"Bacterial, mycobacterial, and protozoal infections after liver transplantation\u2014part I","volume":"12","author":"Blair","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib6","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/lt.22378","article-title":"Infections in immunocompromised hosts and organ transplant recipients: essentials","volume":"17","author":"Fishman","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1399-0012.2010.01262.x","article-title":"Identifying a targeted population at high risk for infections after liver transplantation in the MELD era","volume":"25","author":"Sun","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/lt.22278","article-title":"Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience","volume":"17","author":"Nafady-Hego","year":"2011","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bpg.2012.01.004","article-title":"Risk factors for infection after liver transplantation","volume":"26","author":"Van Hoek","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2014.07.004_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TP.0b013e3181cbac18","article-title":"R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins","volume":"89","author":"Brown","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib11","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/644501","article-title":"The R753Q polymorphism abrogates toll-like receptor 2 signaling in response to human cytomegalovirus","volume":"49","author":"Brown","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.tp.0000276960.35313.bf","article-title":"Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus","volume":"84","author":"Eid","year":"2007","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12250-014-3421-2","article-title":"Ficolins and infectious diseases","volume":"29","author":"Ren","year":"2014","journal-title":"Virol Sin"},{"key":"10.1016\/j.jceh.2014.07.004_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/lt.21834","article-title":"Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation","volume":"15","author":"Cervera","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/596313","article-title":"Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation","volume":"48","author":"Worthley","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gastro.2005.06.049","article-title":"Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation","volume":"129","author":"Bouwman","year":"2005","journal-title":"Gastroenterology"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2014.07.004_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0213-005X(12)70081-2","article-title":"Multidrug-resistant bacterial infection in solid organ transplant recipients","volume":"30","author":"Cervera","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jceh.2014.07.004_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/lt.23845","article-title":"Impact of pretransplant rifaximin therapy on early post-liver transplant infections","author":"Esfeh","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/lt.22212","article-title":"Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation","volume":"17","author":"Benson","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib20","article-title":"Revision liver transplant for persistent infection and localized aspergillosis after hepatic artery thrombosis","author":"Jafarian","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/lt.23518","article-title":"Intercurrent infection predicts mortality in patients with late hepatic artery thrombosis listed for liver retransplantation","volume":"18","author":"Leithead","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/s-0032-1326411","article-title":"Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation","volume":"45","author":"Poley","year":"2013","journal-title":"Endoscopy"},{"key":"10.1016\/j.jceh.2014.07.004_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.transproceed.2013.02.067","article-title":"Risk factors for early bacterial infections in liver transplantation","volume":"45","author":"Avkan-Oguz","year":"2013","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.jceh.2014.07.004_bib24","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.transproceed.2013.08.010","article-title":"Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005\u20132011","volume":"45","author":"Sganga","year":"2013","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.jceh.2014.07.004_bib25","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.transproceed.2011.09.003","article-title":"Urinary tract infections in the early posttransplant period after liver transplantation: etiologic agents and their susceptibility","volume":"43","author":"Kawecki","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2014.07.004_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.12798","article-title":"Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes","author":"Mittal","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.jceh.2014.07.004_bib27","first-page":"139","article-title":"Infectious complications after liver transplantation according to donor: comparison between orthotopic and living donor transplantation","volume":"36","author":"Ki","year":"2004","journal-title":"Infect Chemother"},{"issue":"11","key":"10.1016\/j.jceh.2014.07.004_bib28","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/TP.0b013e31816f61a6","article-title":"Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients","volume":"85","author":"Saner","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.20995","article-title":"Outcomes in hepatitis C virus-infected recipients of living donor versus deceased donor liver transplantation","volume":"13","author":"Terrault","year":"2007","journal-title":"Liver Transpl"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.07.004_bib30","first-page":"117","article-title":"A\u00a0case of cerebral tuberculosis after liver transplant and literature review","volume":"12","author":"Tunca","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7182\/pit2014398","article-title":"Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era","volume":"24","author":"Sun","year":"2014","journal-title":"Prog Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib32","first-page":"251","article-title":"Tuberculosis transmitted through transplantation","volume":"43","author":"Graham","year":"2001","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jceh.2014.07.004_bib33","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","article-title":"Clinical features and outcomes of tuberculosis in solid organ transplant recipients","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.jceh.2014.07.004_bib34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1463-1318.2007.01337.x","article-title":"Intra-abdominal and gastrointestinal tuberculosis","volume":"9","author":"Rasheed","year":"2007","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib36","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202903","article-title":"Disseminated tuberculosis following liver transplant presenting with an axillary abscess","author":"Ladds","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jceh.2014.07.004_bib38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/lt.23480","article-title":"Chemoprophylaxis with isoniazid in liver transplant recipients","volume":"18","author":"F\u00e1brega","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/tid.12027","article-title":"QuantiFERON-TB Gold in Tube test for diagnosis of latent tuberculosis (TB) in solid organ transplant candidates: a single-center study in an area endemic for TB","volume":"15","author":"Ahmadinejad","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib41","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/420746","article-title":"Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients","volume":"38","author":"Doucette","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tid.12170","article-title":"Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study","volume":"16","author":"Longworth","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00029330-200804010-00010","article-title":"Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation","volume":"121","author":"Shi","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jceh.2014.07.004_bib44","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/01.TP.0000065178.93741.72","article-title":"Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study","volume":"75","author":"Husain","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00007890-199402150-00014","article-title":"Candida carriage in the alimentary tract of liver transplant candidates","volume":"57","author":"Kusne","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/lt.20667","article-title":"Viral and fungal infections after liver transplantation \u2013 part II","volume":"12","author":"Kusne","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib47","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib48","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1086\/320904","article-title":"Prevention of fungal and hepatitis virus infections in liver transplantation","volume":"33","author":"Paya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-199707150-00013","article-title":"Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database","volume":"64","author":"Badley","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/lt.21826","article-title":"Antifungal prophylaxis in liver transplant recipients","volume":"15","author":"Eschenauer","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib51","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20690","article-title":"Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis","volume":"12","author":"Cruciani","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-6143.2007.02089.x","article-title":"Antifungal management practices in liver transplant recipients","volume":"8","author":"Singh","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib53","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.ijid.2011.01.005","article-title":"Invasive fungal infections in liver transplantation","volume":"15","author":"Liu","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/hpb.12006","article-title":"Once weekly fluconazole for antifungal prophylaxis post-liver transplantation","volume":"15","author":"Trudeau","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2014.07.004_bib55","doi-asserted-by":"crossref","first-page":"E454","DOI":"10.1111\/ctr.12129","article-title":"Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era","volume":"27","author":"Saliba","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib56","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.transproceed.2012.09.067","article-title":"Opportunistic pulmonary infections in solid organ transplant recipients","volume":"44","author":"Hoyo","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2014.07.004_bib57","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/infdis\/166.6.1379","article-title":"Factors associated with invasive lung aspergillosis and the significance of positive aspergillus culture after liver transplantation","volume":"166","author":"Kusne","year":"1992","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.jceh.2014.07.004_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.crad.2007.12.009","article-title":"Radiological and clinical findings of pulmonary aspergillosis following solid organ transplant","volume":"63","author":"Park","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jceh.2014.07.004_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01603.x","article-title":"Update on invasive aspergillosis: clinical and diagnostic aspects","volume":"12","author":"Munoz","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jceh.2014.07.004_bib60","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1086\/343804","article-title":"Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients","volume":"186","author":"Maertens","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib62","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/iai.59.8.2586-2594.1991","article-title":"The 18-kilodalton antigen secreted by Aspergillus fumigatus","volume":"59","author":"Latge","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.jceh.2014.07.004_bib63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1\u2013>3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan","volume":"43","author":"Pazos","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jceh.2014.07.004_bib64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00007890-199709150-00009","article-title":"Invasive aspergillosis in liver transplant recipients in the 1990s","volume":"64","author":"Singh","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/lt.21099","article-title":"Risk factors for invasive aspergillosis in living donor liver transplant recipients","volume":"13","author":"Osawa","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients","volume":"8","author":"Fort\u00fan","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/430602","article-title":"Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case\u2013control study","volume":"41","author":"Gavalda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12659\/AOT.881989","article-title":"Invasive fungal infections following liver transplantation \u2013 risk factors, incidence and outcome","volume":"16","author":"Pacholczyk","year":"2011","journal-title":"Ann Transplant"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.07.004_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11315510-000000000-00000","article-title":"Clinical aspects of invasive candidiasis in solid organ transplant recipients","volume":"69","author":"Grossi","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.jceh.2014.07.004_bib70","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1432-2277.2003.tb00309.x","article-title":"Longitudinal study of cryptococcosis in adult solid-organ transplant recipients","volume":"16","author":"Vilchez","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2014.07.004_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6002\/ect.2012.0288","article-title":"Donor-derived Cryptococcus infection in liver transplant: case report and literature review","volume":"12","author":"Chang","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-3062.2002.t01-1-02005.x","article-title":"Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients","volume":"4","author":"Wu","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib74","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/cid\/cit593","article-title":"Histoplasmosis after solid organ transplant","volume":"57","author":"Assi","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib75","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/604712","article-title":"Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplantcenter in an endemic area","volume":"49","author":"Cuellar-Rodriguez","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-6143.2010.03328.x","article-title":"Coccidioidomycosis in liver transplant recipients in an endemic area","volume":"11","author":"Vucicevic","year":"2011","journal-title":"Am J Transplant"},{"issue":"S1","key":"10.1016\/j.jceh.2014.07.004_bib77","first-page":"S23","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Getrikkos","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib78","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib79","first-page":"1373","article-title":"Practice guidelines for diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-010-0129-9","article-title":"Recent advances in the treatment of mucormycosis","volume":"12","author":"Spellberg","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jceh.2014.07.004_bib81","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-3062.2012.00740.x","article-title":"Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past","volume":"14","author":"Wang","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib82","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","article-title":"Pneumocystis jiroveci pneumonia in non-HIV-infected patients: new risks and diagnostic tools","volume":"24","author":"Reid","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib83","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1111\/j.1600-6143.2009.02914.x","article-title":"Pneumocystis pneumonia in solid organ transplant recipients","volume":"9","author":"Martin","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0032-1301739","article-title":"Infectious complications after orthotopic liver transplantation","volume":"33","author":"Patel","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib85","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib86","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1432-2277.2009.00907.x","article-title":"CMV infection, diagnosis and antiviral strategies after liver transplantation","volume":"22","author":"Lautenschlager","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2014.07.004_bib87","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.3748\/wjg.14.4849","article-title":"Cytomegalovirus infection after liver transplantation: current concepts and challenges","volume":"14","author":"Razonable","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.07.004_bib88","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib89","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","article-title":"International consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"89","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib90","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/lt.23540","article-title":"Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience","volume":"18","author":"Wadhawan","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib91","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/lt.22144","article-title":"Cytomegalovirus infection after liver transplantation","volume":"16","author":"Razonable","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib92","series-title":"Transplant Infections","first-page":"298","article-title":"Cytomegalovirus infection after solid organ transplantation","author":"Paya","year":"2003"},{"key":"10.1016\/j.jceh.2014.07.004_bib93","first-page":"125","article-title":"The direct and indirect effects of infection in liver transplantation: pathogenesis, impact and clinical management","volume":"22","author":"Rubin","year":"2002","journal-title":"Curr Clin Top Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib94","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/01.TP.0000157867.98649.F5","article-title":"Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years","volume":"79","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/jlts.2002.32282","article-title":"Impact of cytomegalovirus infection, year of transplantation, and donorage on outcomes after liver transplantation for hepatitis C","volume":"8","author":"Burak","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib96","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2012.09.010","article-title":"Liver transplantation in the setting of chronic HCV","volume":"26","author":"Terrault","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2014.07.004_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/317929","article-title":"Human beta-herpesvirus interactions in solid organ transplant recipients","volume":"183","author":"Mendez","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1386-6532(02)00101-4","article-title":"CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients","volume":"25","author":"Lautenschlager","year":"2002","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jceh.2014.07.004_bib99","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Manez","year":"1997","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/hep.510250135","article-title":"Persistent cytomegalovirus in liver allografts with chronic rejection","volume":"25","author":"Lautenschlager","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.07.004_bib101","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0168-8278(99)80294-3","article-title":"Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of the liver grafts","volume":"31","author":"Evans","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.07.004_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients","volume":"28","author":"Roman","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.jceh.2014.07.004_bib103","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.1840180231","article-title":"Intercellular immune adhesion molecules in human liver transplants: overview on expression patterns of leukocyte receptor and ligand molecules","volume":"18","author":"Steinhoff","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.07.004_bib104","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.510270415","article-title":"Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts","volume":"27","author":"Martelius","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.07.004_bib105","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)64638-X","article-title":"Inductions of vascular adhesion protein-1 (VAP-1) during liver allograft rejection and concomitant CMV infection in rats","volume":"157","author":"Martelius","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jceh.2014.07.004_bib106","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hep.1840160202","article-title":"Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome","volume":"16","author":"Arnold","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.07.004_bib107","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3748\/wjg.v10.i13.1857","article-title":"Cytomegalovirus and chronic allograft rejection in liver transplantation","volume":"10","author":"Gao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.07.004_bib108","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM199104113241509","article-title":"Preemptive therapy in immunocompromised hosts","volume":"324","author":"Rubin","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib109","first-page":"4","article-title":"Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop 2007","volume":"15","author":"Griffiths","year":"2008","journal-title":"Herpes"},{"key":"10.1016\/j.jceh.2014.07.004_bib110","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-6143.2007.02026.x","article-title":"CMV survey of CMV prevention strategies after liver transplantation","volume":"8","author":"Levitsky","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib111","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1399-0012.2007.00761.x","article-title":"Emerge of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes","volume":"22","author":"Eid","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib112","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.TP.0000145989.22373.03","article-title":"Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis","volume":"78","author":"Limaye","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib113","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipient in the era of antiviral prophylaxis","volume":"8","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib114","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib115","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-6143.2009.02898.x","article-title":"Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant recipients","volume":"9","author":"Allen","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib116","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOT.0b013e3283465715","article-title":"Posttransplant lymphoproliferative disease following liver transplantation","volume":"16","author":"Kamdar","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib117","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.meg.0000231752.50587.ae","article-title":"Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?","volume":"18","author":"Burra","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.07.004_bib118","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","article-title":"Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience","volume":"236","author":"Jain","year":"2002","journal-title":"Ann Surg"},{"issue":"pt 1","key":"10.1016\/j.jceh.2014.07.004_bib119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib120","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/lt.21152","article-title":"Posttransplantation lymphoproliferative disorder\u2014the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus","volume":"13","author":"Koch","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib121","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1259\/bjr\/63272556","article-title":"Post-transplant lymphoproliferative disease in liver transplantation","volume":"80","author":"Dhillon","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jceh.2014.07.004_bib122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jhep.2005.10.009","article-title":"What is the current treatment of PTLD after liver transplantation?","volume":"44","author":"Dufour","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.07.004_bib123","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1016\/j.transproceed.2005.10.031","article-title":"Fulminant hepatic failure from herpes simplex virus: post liver transplantation acyclovir therapy and literature review","volume":"37","author":"Montalbano","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2014.07.004_bib124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1399-0012.2003.02104.x","article-title":"Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection","volume":"17","author":"Razonable","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib126","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/jlts.2002.34966","article-title":"The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation","volume":"8","author":"Razonable","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib127","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/00007890-200006270-00015","article-title":"Human herpesvirus-6 antigenemia after liver transplantation","volume":"69","author":"Lautenschlager","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jceh.2014.07.004_bib128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1432-2277.2012.01443.x","article-title":"Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review","volume":"25","author":"Lautenschlager","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2014.07.004_bib129","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1097\/00007890-200006270-00016","article-title":"Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome","volume":"69","author":"Rogers","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.07.004_bib130","first-page":"137291","article-title":"Visceral Kaposi's sarcoma related to human herpesvirus-8 in liver transplant recipient: case report and literature review","author":"Benhammane","year":"2012","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007890-200007270-00030","article-title":"Persistent human herpesvirus 8 viremia before Kaposi\u2019s sarcoma development in a liver transplant recipient","volume":"70","author":"Pozo","year":"2000","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jceh.2014.07.004_bib132","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2012.04290.x","article-title":"Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients","volume":"13","author":"Lebbe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib133","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/340237","article-title":"Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients","volume":"185","author":"Jenkins","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clindermatol.2013.01.008","article-title":"Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies","volume":"31","author":"Ruocco","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jceh.2014.07.004_bib135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1586\/eri.11.138","article-title":"The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients","volume":"9","author":"Nelson","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jceh.2014.07.004_bib136","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib137","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/lt.21958","article-title":"Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients","volume":"16","author":"Pischke","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.07.004_bib139","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.transproceed.2012.08.020","article-title":"Hepatitis E virus infection in a liver transplant recipient in the United States: a case report","volume":"45","author":"Te","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2014.07.004_bib140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jceh.2014.07.004_bib141","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1111\/j.1399-0012.2011.01409.x","article-title":"Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis","volume":"25","author":"Skagen","year":"2011","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.jceh.2014.07.004_bib142","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1399-0012.2010.01254.x","article-title":"Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature","volume":"24","author":"Avelino-Silva","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2014.07.004_bib143","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS Disease Transmission Advisory Committee","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.jceh.2014.07.004_bib144","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid1808.120277","article-title":"Infectious disease transmission during organ and tissue transplantation","volume":"18","author":"Greenwald","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jceh.2014.07.004_bib145","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2014.07.004_bib146","first-page":"1021","article-title":"West Nile virus infections in organ transplant recipients\u2014New York and Pennsylvania, August\u2013September, 2005","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2014.07.004_bib147","first-page":"1263","article-title":"West Nile virus transmission via organ transplantation and blood transfusion\u2013Louisiana, 2008","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.jceh.2014.07.004_bib148","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/cid\/cis519","article-title":"Transmission of infection with human allografts: essential considerations in donor screening","volume":"55","author":"Fishman","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jceh.2014.07.004_bib149","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2011.03907.x","article-title":"A\u00a0consolidated biovigilance system for blood, tissue and organs: one size does not fit all","volume":"12","author":"Pruett","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jceh.2014.07.004_bib150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cld.2013.07.013","article-title":"Hepatotoxicity and drug interactions in liver transplant candidates and recipients","volume":"17","author":"Parikh","year":"2013","journal-title":"Clin Liver Dis"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314003478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314003478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:25Z","timestamp":1760853745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314003478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0973688314003478"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.07.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections After Orthotopic Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}